ARDEX UK and Building Adhesives Ltd (BAL) UK have made an announcement on their new leadership structure following the decision to consolidate the activities of all UK teams.

The ARDEX Group is a global solution and service provider of building systems, with 55 subsidiaries and 3,450 employees in over 100 countries on all continents.

A company spokesperson said: “As part of the ARDEX Group of companies within the UK, both ARDEX UK and Building Adhesives Ltd (BAL) businesses are quite rightly very proud of their history and their own distinct cultures and it is this heritage we have been building on, to progressively develop one culture, with one mindset, with everyone acting as one team and sharing one vision.”

At the beginning of 2021, ARDEX UK and Building Adhesives Limited (BAL) moved ahead with the next


ANTIBACTERIAL TILES Parkside has launched four new wall and floor tile collections with built-in antibacterial protection.

Years of research have resulted in wall and floor tile collections with antibacterial protection. Inspired by nature, the collection’s built- in technology uses tin oxide and titanium oxide to create a finish that is antibacterial and anti-viral.

Now available in Beat, Sylkin, Larkham and Tyne, the technology is proven to eliminate 99.7% of common bacteria. Unlike similar products, where the antibacterial properties fade with time, Parkside’s protection is permanent and lasts for the lifetime of the tile. In fact, the technology is enhanced by solar and artificial light, yet still performs under dark conditions.

Making businesses and public spaces safer and more hygienic around the clock, the tiles also require less use of cleaning chemicals or detergents,

phase of their ‘Stronger Together’ strategy with a new leadership structure taking responsibility for the UK Commercial teams.

Reporting into David Hackett, General Manager - Building Adhesives Ltd (BAL), David Lyman, formerly BAL Sales & Marketing Director will take on the new role of UK Commercial Director with responsibility for the key functional areas of Tiling, Flooring and the Home Improvement Channel (HIC).

while bad odours are also eliminated. Available in a range of looks, including authentic Tyne brick in red and white and delivering 36+ PTV, the collection answers the need for floors, walls and surfaces that are durable and easy to keep safe in hospitality, leisure and other commercial projects.

Brian Linnington, Managing Director, Parkside, said: “This new technology has been years in development and represents a significant step in hygienic porcelain wall and floor tiles. Not only antibacterial but anti-viral as well, the collection can help businesses with a more sanitary tile surface that is easier to keep clean.”

Parkside recommends the use of an epoxy or antimicrobial grout.

Epoxide-resin-based grouts are impermeable so provide a degree of inherent protection, while remaining easy to clean thanks to a smooth surface. Containing Microban, antimicrobial grout continually destroys and inhibits the growth of bacteria, mould and mildew.

For further information, email info@ or call 0116 276 2532 — 11 —

UK Marketing and Training will also report into David Lyman. Andy Reid, formerly ARDEX Business Development Director takes on the recently formed role of UK Business Development Director overseeing major project specification selling across the UK for both ARDEX and BAL, also reporting into David Hackett.

Peter Bell remains as the Managing Director of both businesses and member of the ARDEX Group Global Management Committee.

As part of his pre-retirement plan until July 2021, Lee Kidd - ARDEX Sales & Marketing Director will provide support to the newly re- structured UK Commercial Team and support the business transformation with his vast experience of the respective markets.

The move consolidates the activities of all UK teams and more formally combines the forces of ARDEX and BAL for a stronger and more coordinated approach to the market.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34